| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/05/2003 | CN1400018A Medicine for curing adiposis, diabetes and related diseases |
| 03/05/2003 | CN1399976A Chinese medicine powder preparation for resisting thrombosis and its preparation method |
| 03/05/2003 | CN1102660C Antihumanfibrin monoclonal antibody heavy chain and light chain variable region gene and its application |
| 03/05/2003 | CN1102409C Triple live chicken vaccine and its production process |
| 03/05/2003 | CN1102382C Preparation and methods for the treatment of T cell mediated diseases |
| 03/05/2003 | CA2356438A1 Use of terpenes and derivatives as potentiators of antitumor agents in the treatment of cancers |
| 03/04/2003 | US6528699 Inserting nucleic acid construct which comprises promoter, milk protein specific signal sequence; can use for treating diabetes and multiple sclerosis |
| 03/04/2003 | US6528634 Aiolos gene |
| 03/04/2003 | US6528626 Viral library for use in the diagnosis and treatment of viral diseases |
| 03/04/2003 | US6528623 Antibodies that specifically bind ACT-4-L-h-1 ligand |
| 03/04/2003 | US6528493 Modulating activity of endogenous protein |
| 03/04/2003 | US6528482 Receptor activator of NF-κB |
| 03/04/2003 | US6528307 Stable cloned T-lymphocyte cell line; use therapy, bioassay, drug screening, anticancer agent |
| 03/04/2003 | US6528304 Eukaryotic cells expressing at their surface at least an HLA-G isoform and their applications |
| 03/04/2003 | US6528294 To effect protein phosphorylation; for use in diagnosis and therapy |
| 03/04/2003 | US6528263 Identifying a cell expressing protooncogene polypeptide by contacting a nucleic acid with a polynucleotide reagent and detecting its binding; can be used in diagnosis and treatment of cancer |
| 03/04/2003 | US6528253 Compositions and methods for diagnosis of ovarian cancer |
| 03/04/2003 | US6528066 Variant varicella-zoster viruses and methods of use |
| 03/04/2003 | US6528065 Attenuated dengue-3 virus vaccine |
| 03/04/2003 | US6528064 Recombinant trytophan mutants of influenza |
| 03/04/2003 | US6528063 Infectious bursal disease virus (IBDV); viral proteins transgenically expressed in plant cells or viral protein coding sequences cloned into an E. Coli expression system administered to poultry |
| 03/04/2003 | US6528061 purified immunogenic polypeptide comprising a polysaccharide mimotope recognized by a protective monoclonal antibody having a specificity for a surface polysaccharide of a bacterium of the Shigella species, said surface polysaccharide |
| 03/04/2003 | US6528060 Therapeutic compounds |
| 03/04/2003 | US6528059 Specific epitopic regions of thyroid peroxidase (TPO), a thyroid specific membrane autoantigen, have been identified within amino acid residues protein (SEQ ID NO:2), with at least one distinct binding region within TPO located from |
| 03/04/2003 | US6528058 Saponin adjuvant composition |
| 03/04/2003 | US6528056 Inhibition of viral infection using antigen-binding proteins |
| 03/04/2003 | US6528055 Polypeptide for use in the diagnosis, treatment and prevention of infections, immune response defects and autoimmune diseases |
| 03/04/2003 | US6528054 Comprise one or more breast tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions. Alternatively, a therapeutic composition may comprise an antigen presenting cell that expresses a breast |
| 03/04/2003 | US6528038 An immune response directed against Porphyromonas gingivalis. The composition includes a suitable adjuvant and/or acceptable carrier and one substantially purified P. gingivalis immunogen. The immunogen is selected from the group consisting |
| 03/04/2003 | CA1341423C Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome |
| 02/28/2003 | CA2400887A1 Production of therapeutic proteins in transgenic cereal crops |
| 02/28/2003 | CA2356473A1 Production of a herpes vaccine in the seeds of a cereal crop |
| 02/27/2003 | WO2003016917A2 Sodium channel regulators and modulators |
| 02/27/2003 | WO2003016915A1 Tumor specific oligosaccharide sequences and use thereof |
| 02/27/2003 | WO2003016906A1 Method of diagnosing or monitoring saccharometabolic error |
| 02/27/2003 | WO2003016529A1 Novel blomia tropicalis antigens and uses therefor |
| 02/27/2003 | WO2003016522A2 Methods and compounds for the targeting of protein to exosomes |
| 02/27/2003 | WO2003016512A1 Method for improving methods of immunotherapy |
| 02/27/2003 | WO2003016511A1 Method of extended culture for antigen-specific cytotoxic t lumphocytes |
| 02/27/2003 | WO2003016506A2 Secreted proteins |
| 02/27/2003 | WO2003016493A2 Transporters and ion channels |
| 02/27/2003 | WO2003016491A2 Retrovirus isolated from mantle histiocytes in mantle cell lymphoma |
| 02/27/2003 | WO2003016470A2 Enhancing the efficacy of immunotherapies by supplementing with complement |
| 02/27/2003 | WO2003016468A2 Antagonistic anti-htnfsf13b human antibodies |
| 02/27/2003 | WO2003016467A2 Use of antibodies having high affinity for soluble ass to treat conditions and diseases related to ass |
| 02/27/2003 | WO2003016466A2 ANTI-Aβ ANTIBODIES |
| 02/27/2003 | WO2003016464A2 Cancer specific oligosaccharide sequences and use thereof |
| 02/27/2003 | WO2003016354A2 Recombinant anti-plasmodium falciparum antibodies |
| 02/27/2003 | WO2003016350A1 A method of producing antibodies ex-vivo |
| 02/27/2003 | WO2003016344A2 Use of lung carcinoma antigen |
| 02/27/2003 | WO2003016340A1 Derp1 and proderp1 allergen derivatives |
| 02/27/2003 | WO2003016333A2 Virus coat protein/receptor chimeras and methods of use |
| 02/27/2003 | WO2003015850A1 Method for inducing selectively suppressed immune response |
| 02/27/2003 | WO2003015825A2 Conjugate |
| 02/27/2003 | WO2003015819A1 Complement pathway inhibitors binding to c5 and c5a without preventing formation of c5b |
| 02/27/2003 | WO2003015817A2 Oral immunoglobulin treatment for inflammatory bowel disease |
| 02/27/2003 | WO2003015816A1 Immunomodulatory oligonucleotide formulations and methods for use thereof |
| 02/27/2003 | WO2003015815A1 Improved conjugate vaccines |
| 02/27/2003 | WO2003015813A2 Anti-tumor vaccines |
| 02/27/2003 | WO2003015812A2 Beta-amyloid-analogue-t-cell epitop vaccine |
| 02/27/2003 | WO2003015796A1 Imunogenic conjugate of carbohydrate haptens and aggregated protein carrier |
| 02/27/2003 | WO2003015775A1 New dipeptidyl peptidase iv inhibitors and their uses for lowering blood pressure levels |
| 02/27/2003 | WO2003015744A1 Chitin microparticles and their medical uses |
| 02/27/2003 | WO2003015713A2 Treatment of glial tumors with glutamate antagonists |
| 02/27/2003 | WO2003015712A2 Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin |
| 02/27/2003 | WO2003015705A2 In situ immunization |
| 02/27/2003 | WO2003015702A2 Epitopes of human immunodeficiency virus-1 |
| 02/27/2003 | WO2003015697A2 Interleukin-2 mutants with reduced toxicity |
| 02/27/2003 | WO2003015694A2 Agents for enhancing the immune response |
| 02/27/2003 | WO2003015506A1 Propagation of human hepatoblastoma cell in non-human animals |
| 02/27/2003 | WO2003000894A9 Polynucleotide vaccine |
| 02/27/2003 | WO2003000204A3 Multivalent mycoplasma bacterin |
| 02/27/2003 | WO2002102324A9 Anti-arthropod vector vaccines methods of selecting and uses thereof |
| 02/27/2003 | WO2002100348A3 Human monoclonal antibodies to epidermal growth factor receptor (egfr) |
| 02/27/2003 | WO2002091998A3 Novel meningitis conjugate vaccine |
| 02/27/2003 | WO2002086083A3 Methods of enhancing cell responsiveness |
| 02/27/2003 | WO2002080851A3 Chimeric vaccines |
| 02/27/2003 | WO2002072026A3 In situ langerhans cell vaccine |
| 02/27/2003 | WO2002072012A3 A novel proteosome-liposaccharide vaccine adjuvant |
| 02/27/2003 | WO2002068651A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 02/27/2003 | WO2002066629A8 Recombinant vector containing infectious human cytomegalovirus genome with preserved wild-type characteristics of clinical isolates |
| 02/27/2003 | WO2002064736A3 Protein-protein interactions |
| 02/27/2003 | WO2002062203A3 Compositions and methods for the therapy and diagnosis of breast cancer |
| 02/27/2003 | WO2002058717A3 Methods for treating rheumatoid arthritis using il-17 antagonists |
| 02/27/2003 | WO2002056908A3 Artificial antigen-presenting cells |
| 02/27/2003 | WO2002055555A3 Antigenic ck-18 compounds for therapy and diagnosis and methods for using same |
| 02/27/2003 | WO2002053168A3 Sterilising pill |
| 02/27/2003 | WO2002044336A3 Method of making a protein polymer and uses of the polymer |
| 02/27/2003 | WO2002032378A3 Fusion cells and cytokine compositions for treatment of disease |
| 02/27/2003 | WO2002031156A3 Bvh-a2 and bvh-a3 antigens of group b streptococcus |
| 02/27/2003 | WO2002028425A3 Methods for treating muscle injuries |
| 02/27/2003 | WO2002022212A3 Combination therapy for treatment of autoimmune diseases using b cell depleting/immunoregulatory antibody combination |
| 02/27/2003 | WO2002016548A8 Novel g protein-coupled receptor |
| 02/27/2003 | WO2002008436A3 Mini-adenoviral vector system for vaccination |
| 02/27/2003 | WO2002008267A3 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 02/27/2003 | WO2002002797A3 Regulation of human 11 beta-hydroxysteroid dehydrogenase 1-like enzyme |
| 02/27/2003 | WO2002000691A3 Polynucleotides and polypeptides encoded thereby |
| 02/27/2003 | WO2001098471A3 Human phosphodiesterases |
| 02/27/2003 | WO2001079555A3 Roles of jak/stat family members in tolerance induction |
| 02/27/2003 | US20030040617 For detecting, prophylaxis and therapy of disorders of the colon and/or rectum, including, but not limited to, the presence of colorectal cancer and colorectal cancer metastases |